REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386 | -54.4% | 33,683 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $847 | -38.1% | 33,454 | -21.3% | 0.00% | -50.0% |
| Q1 2023 | $1,369 | +41.0% | 42,490 | -19.2% | 0.00% | +100.0% |
| Q4 2022 | $971 | -99.9% | 52,608 | +4.0% | 0.00% | -50.0% |
| Q3 2022 | $1,366,000 | +95.7% | 50,598 | +0.2% | 0.00% | +100.0% |
| Q2 2022 | $698,000 | -29.3% | 50,487 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $987,000 | +19.5% | 50,622 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $826,000 | -41.5% | 50,599 | -0.3% | 0.00% | -50.0% |
| Q3 2021 | $1,413,000 | -21.6% | 50,734 | -16.6% | 0.00% | 0.0% |
| Q2 2021 | $1,803,000 | +13.0% | 60,818 | +6.5% | 0.00% | 0.0% |
| Q1 2021 | $1,596,000 | -1.4% | 57,100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,618,000 | +23.5% | 57,100 | +9.6% | 0.00% | 0.0% |
| Q3 2020 | $1,310,000 | +3.0% | 52,100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,272,000 | +95.7% | 52,100 | +18.7% | 0.00% | +100.0% |
| Q1 2020 | $650,000 | +1.4% | 43,900 | +11.1% | 0.00% | 0.0% |
| Q4 2019 | $641,000 | +4.7% | 39,500 | -16.1% | 0.00% | 0.0% |
| Q3 2019 | $612,000 | +0.2% | 47,100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $611,000 | +23.2% | 47,100 | +49.5% | 0.00% | 0.0% |
| Q1 2019 | $496,000 | -21.8% | 31,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $634,000 | -30.1% | 31,500 | -13.7% | 0.00% | 0.0% |
| Q3 2018 | $907,000 | -9.5% | 36,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,002,000 | +11.5% | 36,500 | +25.0% | 0.00% | 0.0% |
| Q1 2018 | $899,000 | -12.3% | 29,200 | +1.9% | 0.00% | 0.0% |
| Q4 2017 | $1,025,000 | +59.7% | 28,662 | +23.0% | 0.00% | 0.0% |
| Q3 2017 | $642,000 | +4.4% | 23,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $615,000 | +26.8% | 23,300 | -0.0% | 0.00% | 0.0% |
| Q1 2017 | $485,000 | +24.0% | 23,301 | +23.3% | 0.00% | 0.0% |
| Q4 2016 | $391,000 | +27.8% | 18,900 | 0.0% | 0.00% | – |
| Q3 2016 | $306,000 | +19.1% | 18,900 | 0.0% | 0.00% | – |
| Q2 2016 | $257,000 | -22.1% | 18,900 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $330,000 | -41.8% | 18,900 | +13.9% | 0.00% | 0.0% |
| Q4 2015 | $567,000 | +28.9% | 16,600 | +12.2% | 0.00% | 0.0% |
| Q3 2015 | $440,000 | +0.2% | 14,800 | +7.7% | 0.00% | 0.0% |
| Q2 2015 | $439,000 | – | 13,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |